DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20170044

Prevalence of functional constipation and constipation-predominant irritable bowel syndrome in Indian patients with constipation

Ramesh Rooprai, Naresh Bhat, Rajesh Sainani, Mayur M. Mayabhate

Abstract


Background: Evaluate prevalence of functional constipation (FC) and irritable bowel syndrome-constipation (IBS-C) in Indian constipated patients and assess their demographic/socio-economic/clinical characteristics.

Methods: Patients (≥18 years) who visited their general physician with symptoms of constipation (Rome III criteria for FC or IBS-C as per physician assessment) and willing to participate were enrolled in this prospective, clinical-epidemiological study. Demographic, socioeconomic status, lifestyle and dietary habits, comorbid conditions, treatment history, concomitant medications, stool form (Bristol stool form scale), severity of constipation (constipation scoring system [CSS]), constipation-related symptoms (patient assessment of constipation symptoms [PAC-SYM]) and quality of life (patient assessment of constipation-quality of life questionnaire [PAC-QoL]) were recorded.

Results: Out of 925 constipated patients, 75.6% were diagnosed with FC against 24.4% with IBS-C (P < 0.0001). Patients of both subtypes had high average scores of PAC-SYM (FC: 27.1 ± 6; IBS-C: 30.1 ± 4.9) and CSS (FC: 8.4 ± 3.1; IBS-C: 11.2 ± 3), leading to high PAC-QoL score (FC: 38.1 ± 16.8; IBS-C: 42.2 ± 13.6). Hypertension (16%) and diabetes (10%) in patients with FC while acid peptic disorders (21.7%) amongst IBS-C patients were the most common comorbid conditions observed. Laxatives were the most common medication used; osmotic (32.6% versus 40.7%) and bulk laxatives (22.8% versus 37.4%) were the commonest laxatives. However, about 1/5th patients of FC were using home remedies.

Conclusions: There was a higher prevalence of FC over IBS-C in Indian constipated patients; both subtypes had high frequency and severity of constipation-related symptoms and poor QoL.


Keywords


Constipation scoring system, Co-morbid conditions, Laxatives, PAC-SYM, PAC-QoL

Full Text:

PDF

References


Jamshed N. Diagnostic Approach to Chronic Constipation in Adults. Am Fam Physician. 2011;84:299-306.

Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterol. 2006;130:1480-91.

Sun SX, Dibonaventura M, Purayidathil FW, Wagner JS, Dabbous O, Mody R. Impact of chronic constipation on health-related quality of life, work productivity, and healthcare resource use: an analysis of the National Health and Wellness Survey. Dig Dis Sci. 2011;56:2688-95.

Gonzalez-Martinez MA, Ortiz-Olvera NX, Mendez-Navarro J. Novel pharmacological therapies for management of chronic constipation. J Clin Gastroenterol. 2014;48:21-8.

Remes Troche JM, Remes Troche JM, Tamayo de la Cuesta JL, Raña Garibay R, Huerta Iga F, Suarez Morán E, et al. Association Mexicana de Gastroenterología. [Guidelines for diagnosis and treatment of constipation in Mexico. A) Epidemiology (meta-analysis of the prevalence), pathophysiology and classification]. Rev Gastroenterol Mex. 2011;76:126-32.

Lopez CA, Rivera RJF, Sobrino CS, Suárez ME. [Gastroenterology diagnosis and treatment guidelines of irritable bowel syndrome; epidemiology and physiopathology]. Rev Gastroenterol Mex. 2009;74:56-7.

Suares NC, Ford AC. Prevalence of, and risk factors for, chronic idiopathic constipation in the community: systematic review and metaanalysis. Am J Gastroenterol. 2011;106:1582.

Bharucha AE, Dorn SD, Lembo A, Pressman A. American Gastroenterological Association medical position statement on constipation. Gastroenterology. 2013;144:211-7.

Chaud D, Olivon E, Machado A, Abreu E. Prevalence of functional constipation and its risk factors among university students (LB328). The FASEB Journal. 2014;28(1):LB328.

Upadhyay R, Singh A. Irritable Bowel Syndrome: The Indian Scenario. In Medicine Update. 2013. Available at http://www.apiindia.org/medicine_update_2013/chap56.pdf. Accessed 22 Sep 2016.

Chan AO, Lam KF, Hui WM, Hu WH, Li J, Lai KC, et al. Validated questionnaire on diagnosis and symptom severity for functional constipation in the Chinese population. Aliment Pharmacol Ther. 2005;22:483-8.

Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology. 2006;130:1377-90.

Heidelbaugh JJ, Stelwagon M, Miller SA, Shea EP, Chey WD. The spectrum of constipation-predominant irritable bowel syndrome and chronic idiopathic constipation: US survey assessing symptoms, care seeking, and disease burden. Am J Gastroenterol. 2015;110:580-7.

Kasthuri A, Hegde SKB, Joseph MA, Rao DP, Gomez G, Sahu A. Prevalence of constipation among elderly in a rural area of Bangalore. IJRRMS. 2013;3:9-11.

Tack J, Muller-Lissner S. Treatment of chronic constipation: Current pharmacologic approaches and future directions. Clin Gastroenterol Hepatol. 2009;7:502-8.

Pinto Sanchez MI, Bercik P. Epidemiology and burden of chronic constipation. Can J Gastroenterol. 2011;25:11B-5B.

Makharia GK, Verma AK, Amarchand R, Goswami A, Singh P, Agnihotri A, et al. Prevalence of irritable bowel syndrome: a community based study from northern India. J Neurogastroenterol Motil. 2011;17:82-7.

Talley NJ, Zinsmeister AR, Melton IJ 3rd. Irritable bowel syndrome in a community: symptoms subgroups, risk factors and a health care utilization. Am J Epidemiol. 1995;142:76-83.

Luo JC, Lin HY, Chang FY, Lu RH, Lu CL, Chen CY, et al. Occurrence of peptic ulcer disease in connective tissue disease patients associated with xerostomia. Aliment Pharmacol Ther. 2003;17:217-24.

Sandler RS, Jordan MC, Shelton BJ. Demographic and dietary determinants of constipation in the US population. Am J Public Health. 1990;80:185-9.

Zhao YF, Ma XQ, Wang R, Yan XY, Li ZS, Zou DW, et al. Epidemiology of functional constipation and comparison with constipation-predominant irritable bowel syndrome: The Systematic Investigation of Gastrointestinal Diseases in China (SILC). Aliment Pharmacol Ther. 2011;34:1020-9.

Pourhoseingholi MA, Kaboli SA, Pourhoseingholi A, Moghimi-Dehkordi B, Safaee A, Mansoori BK. Obesity and functional constipation; a community-based study in Iran. J Gastrointestin Liver Dis. 2009;18:151-5.

Talley NJ, Quan C, Jones MP, Horowitz M. Association of upper and lower gastrointestinal tract symptoms with body mass index in an Australian cohort. Neurogastroenterol Motil. 2004;16:413-9.

Murakami K, Sasakii S, Okubo H, Takahashi Y, Hoso Y, Itabashi M. Freshmen in Dietetic Courses Study II Group. Food intake and functional constipation: a cross-sectional study of 3,835 Japanese women aged 18-20 years. J Nutr Sci Vitaminol (Tokyo). 2007;53:30-6.

Farzaneh N, Ghobaklou M, Moghimi-Dehkordi B, Naderi N, Fadai F. Effects of demographic factors, body mass index, alcohol drinking and smoking habits on irritable bowel syndrome: a case control study. Ann Med Health Sci Res. 2013;3:391-6.

Khademolhosseini F, Mehrabani D, Nejabat M, Beheshti M, Heydari ST, Mirahmadizadeh A, et al. Irritable bowel syndrome in adults over 35 years in Shiraz, southern Iran: Prevalence and associated factors. J Res Med Sci. 2011;16:200-6.

Lu CL, Chang FY, Chen CY, Luo JC, Lee SD. Significance of Rome II-defined functional constipation in Taiwan and comparison with constipation-predominant irritable bowel syndrome. Aliment Pharmacol Ther. 2006;24:429-38.

Gururaj, Maheshwaran. Kuppuswamy’s socio-economic status scale - a revision of income parameter for 2014. IJRTSAT. 2014;11:01-2.

Higgins PD, Johanson JF. Epidemiology of functional constipation in North America: a systematic review. Am J Gastroenterol. 2004;99:750-9.

Slappendel R, Simpson K, Dubois D, Keininger DL. Validation of the PAC-SYM questionnaire for opioid-induced constipation in patients with chronic low back pain. Eur J Pain. 2006;10:209-17.

Glia A, Lindberg G. Quality of life in patients with different types of functional constipation. Scand J Gastroenterol. 1997;32:1083-9.

Belsey J, Greenfield S, Candy D, Geraint M. Systematic review: impact of constipation on quality of life in adults and children. Aliment Pharmacol Ther. 2010;31:938-49.

Ruiz-López MC, Coss-Adame E. Calidad de vida en pacientes con diferentes subtipos de estre˜nimiento de acuerdo a los criterios de ROMA III. Revista de Gastroenterología de México. 2015;80:13-20.

Brandt LJ, Prather CM, Quigley EM, Schiller LR, Schoenfeld P, Talley NJ. Systematic review on the management of chronic constipation in North America. Am J Gastroenterol. 2005;100:S5-21.

Bijkerk CJ, de Wit NJ, Muris JW, Whorwell PJ, Knottnerus JA, Hoes AW. Soluble or insoluble fibre in irritable bowel syndrome in primary care? Randomised placebo controlled trial. BMJ. 2009;339:b3154.

Chapman RW, Stanghellini V, Geraint M, Halphen M. Randomized clinical trial: macrogol/PEG 3350 plus electrolytes for treatment of patients with constipation associated with irritable bowel syndrome. Am J Gastroenterol. 2013;108:1508-15.

Nellesen D, Chawla A, Oh DL, Weissman T, Lavins BJ, Murray CW. Comorbidities in patients with irritable bowel syndrome with constipation or chronic idiopathic constipation: a review of the literature from the past decade. Postgrad Med. 2013;125:40-50.

Oh JH, Choi MG, Kang MI, Lee KM, Kim JI, Kim BW, et al. The prevalence of gastrointestinal symptoms in patients with non-insulin dependent diabetes mellitus. Korean J Intern Med. 2009;24:309-17.

Yarandi SS, Nasseri-Moghaddam S, Mostajabi P, Malekzadeh R. Overlapping gastroesophageal reflux disease and irritable bowel syndrome: Increased dysfunctional symptoms. World J Gastroenterol. 2010;16:1232-8.

Hosseinzadeh ST, Poorsaadati S, Radkani B, Forootan M. Psychological disorders in patients with chronic constipation. Gastroenterol Hepatol Bed Bench Summer. 2011;4:159-63.